THE WOODLANDS, Texas,
April 15, 2014 /PRNewswire/
-- CB&I (NYSE: CBI) today announced it has been awarded a
contract by Shandong Chengtai Chemical Industry Co., Ltd. for the
license and engineering design of a grassroots iso-butane
dehydrogenation unit to be built in Changyi, Shandong Province, China.
The unit will use the CATOFIN® dehydrogenation
technology offered from CB&I and Clariant's tailor made CATOFIN
catalyst to process iso-butane feed for the production of 114,000
metric tons per year of isobutylene.
"The CATOFIN technology has been selected for 20 projects in the
last five years," said Daniel
McCarthy, President of CB&I's Technology operating
group. "This award is further testament to the success of the
CATOFIN technology and catalyst in allowing customers to process
various feedstocks at ideal conditions for the highest yields."
"CATOFIN technology is a reliable and well proven technology.
The first commercial propane dehydrogenation unit in China was based on CATOFIN technology and has
been in successful operation since October
2013," highlights Stefan
Heuser, Senior Vice President and Head of Business Unit
Catalysts of Clariant.
Isobutylene will be used as a building block to produce MTBE and
other downstream products.
CATOFIN is a registered trademark of Clariant.
About CB&I
CB&I (NYSE:CBI) is the most complete energy infrastructure
focused company in the world and a major provider of government
services. With 125 years of experience and the expertise of
approximately 55,000 employees, CB&I provides reliable
solutions while maintaining a relentless focus on safety and an
uncompromising standard of quality. For more information, visit
www.cbi.com.
About Clariant
Clariant is a globally leading
specialty chemicals company, based in Muttenz near Basel/Switzerland. On December 31, 2013 the company employed a total
workforce of 18,099. In the financial year 2013, Clariant recorded
sales of CHF 6.076 billion for its
continuing businesses. The company reports in four business areas:
Care Chemicals, Catalysis & Energy, Natural Resources, and
Plastics & Coatings. Clariant's corporate strategy is based on
four pillars: managing businesses for profitability, research &
development and innovation, growth in emerging markets, and
repositioning of the portfolio. www.clariant.com.
Important Information For Investors And Shareholders
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements regarding
CB&I and represents our expectations and beliefs concerning
future events. These forward-looking statements are intended to be
covered by the safe harbor for forward-looking statements provided
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements involve known and unknown risks and
uncertainties. When considering any statements that are predictive
in nature, depend upon or refer to future events or conditions, or
use or contain words, terms, phrases or expressions such as
"achieve," "forecast," "plan," "propose," "strategy," "envision,"
"hope," "will," "continue," "potential," "expect," "believe,"
"anticipate," "project," "estimate," "predict," "intend," "should,"
"could," "may," "might" or similar forward-looking statements, we
refer you to the cautionary statements concerning risk factors and
"Forward-Looking Statements" described under "Risk Factors" in Item
1A of our Annual Report filed on Form 10-K filed with the SEC for
the year ended December 31, 2013, and
any updates to those risk factors or "Forward-Looking Statements"
included in our subsequent Quarterly Reports on Form 10-Q filed
with the SEC, which cautionary statements are incorporated herein
by reference.
SOURCE CB&I